Objective : The objective of this study is to evaluate the clinical and angiographic outcomes after primary balloon angioplasty in patients with symptomatic middle cerebral artery (MCA, M1 segment) stenosis refractory to medical therapy. Materials and Methods : Eleven patients with intracranial stenosis were treated with primary balloon angioplasty. All patients had MCA stenosis with recurrent transient ischemic attack (TIA). The indication for balloon angioplasty was patients with significant MCA stenosis: 1) age older than 18 years with recurrent or progressive TIA or infarction despite optimal medical therapy, including anti-coagulation, dual anti-platelet, and anti-lipid medication; 2) previous ischemic events or asymptomatic severe stenosis (more than 50%) with poor collateral cerebral circulation, or diminished cerebral perfusion on single photon emission computed tomography before and after administration of the intravenous dosage of acetazolamide.
INTRODUCTION
The best treatment for middle cerebral artery (MCA) stenosis remains controversial. Outcomes of medical treatment for patients with MCA stenosis are unfavorable.
Reported annual stroke rates are 8%-10%. 22) The warfarin-aspirin symptomatic intracranial disease study reported that medical treatment with warfarin or aspirin resulted in failure to prevent further ischemic events. 4) The 1-year 2-year probability for recurrent stroke in the territory of the stenotic artery in patients treated with aspirin was reported as 12% and 15%, respectively.
4)16)
Recently, in patients with intracranial arterial stenosis, aggressive medical management (SAMPRIS study) was reported to be superior to primary balloon angioplasty with the use of the Wingspan stent system. 4) However, primary balloon angioplasty was found to be effective for selected patients of symptomatic intra- These patients include symptomatic severe MCA stenosis (over 50%) with recurrent symptoms despite adequate medical treatment. In this study, we summarize the clinical and radiological results of primary balloon angioplasty for MCA stenosis. 
MATERIALS AND METHODS

Endovascular procedure
The patients received 100 mg of aspirin and 75 mg clopidogrel daily for at least seven days before the procedure. A bolus of 3000-5000 U of heparin was ad- stenosis in the 50-69% range. All lesions were crossed and dilated successfully. Post-treatment stenosis varied between 5% and 60% (mean 29.1 ± 15.37%). Eight patients (72%) had less than 50% residual stenosis, three patients (28%) had 50-69% stenosis (Table 1) .
Procedural events occurred in four (36.4%) of 11 pa- 17)
The differences include the absence of an external elastic lamina, lack of adventitia, thin media in the arterial wall, and suspension in cerebrospinal fluid. All represent weak arterial walls of cerebral vessels.
The mechanisms of stroke are also different. There are three possible mechanisms of cerebral stroke; thromboembolism, perforator occlusion, and hypoperfusion. 
CONCLUSION
We found a high rate of technical success and a low rate of stroke recurrence and residual stenosis, suggesting that this procedure has a durable effect. 
